Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods

Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods

US Patent 6995183 · Granted Feb 7, 2006

Estimated economic value: $27,761,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors2025
AhR modulators2025
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections2024
Dihydrothieno[3,2-b]pyridine compounds2023
Amido compounds as AhR modulators2023
Substituted imidazo[1,5-a]pyrazines and [1,2,4]triazolo[4,3-a]pyrazines for the 2022
Tricyclic compounds useful to treat orthomyxovirus infections2022
AhR modulators2022
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors2021
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections2021
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors2021
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors2021